Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Agúndez

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1995
Metabolism of aminopyrine and derivatives in man: in vivo study of monomorphic and polymorphic metabolic pathwaysJ A Agúndez, C Martínez, J Benítez
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1992
Caffeine demethylase activity in human and Dark Agouti rat liver microsomes. Comparison with aminopyrine N-demethylase activityJ A Agúndez, A Luengo, J Benítez
Therapeutic Drug Monitoring|June 1, 1994
Determination of aminopyrine, dipyrone and its metabolites in urine by high-performance liquid chromatographyJ A Agúndez, C Martínez, R Martín, et al.
Therapeutic Drug Monitoring|February 1, 1995
Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeineJ A Agúndez, J A Carrillo, C Martínez, et al.
Pharmacogenetics|July 31, 1998
Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamineJ A Agúndez, L Gallardo, C Martínez, et al.
Pharmacogenetics|April 1, 1997
Tryptamine: a possible endogenous substrate for CYP2D6C Martínez, J A Agúndez, G Gervasini, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white populationJ A Agúndez, M C Ledesma, J M Ladero, et al.
Pharmacogenetics|October 1, 1996
Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white populationJ A Agúndez, M Olivera, C Martínez, et al.
Pharmacogenetics|February 24, 2001
Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenalineG Gervasini, C Martínez, J A Agúndez, et al.
Pharmacogenetics|August 1, 1995
Lung cancer and mutations at the polymorphic NAT2 gene locusC Martínez, J A Agúndez, M Olivera, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 1, 1995
Metabolism of aminopyrine and derivatives in man: in vivo study of monomorphic and polymorphic metabolic pathwaysJ A Agúndez, C Martínez, J Benítez
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1992
Caffeine demethylase activity in human and Dark Agouti rat liver microsomes. Comparison with aminopyrine N-demethylase activityJ A Agúndez, A Luengo, J Benítez
Therapeutic Drug Monitoring|June 1, 1994
Determination of aminopyrine, dipyrone and its metabolites in urine by high-performance liquid chromatographyJ A Agúndez, C Martínez, R Martín, et al.
Therapeutic Drug Monitoring|February 1, 1995
Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeineJ A Agúndez, J A Carrillo, C Martínez, et al.
Pharmacogenetics|July 31, 1998
Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamineJ A Agúndez, L Gallardo, C Martínez, et al.
Pharmacogenetics|April 1, 1997
Tryptamine: a possible endogenous substrate for CYP2D6C Martínez, J A Agúndez, G Gervasini, et al.
Clinical Pharmacology and Therapeutics|March 1, 1995
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white populationJ A Agúndez, M C Ledesma, J M Ladero, et al.
Pharmacogenetics|October 1, 1996
Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white populationJ A Agúndez, M Olivera, C Martínez, et al.
Pharmacogenetics|February 24, 2001
Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenalineG Gervasini, C Martínez, J A Agúndez, et al.
Pharmacogenetics|August 1, 1995
Lung cancer and mutations at the polymorphic NAT2 gene locusC Martínez, J A Agúndez, M Olivera, et al.
Pageof 4